NCCN Collaborative Projects in Advanced Ovarian Cancer
Posted: Tuesday, March 24, 2020
In collaboration with AstraZeneca, the National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) has selected four ovarian cancer projects for research funding. Each project will assess a technique designed to improve the quality of care for patients with advanced ovarian cancer. The projects are expected to begin in the third quarter of 2020, with support guaranteed for 2 years.
The selected projects are the following:
- CommunityRx-Cancer: An IT-Enhanced Patient Navigation Program for Social Determinants of Health in Advanced Ovarian Cancer: Cary Gross, MD, Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center and Smilow Cancer Hospital
- Feasibility and Impact of a Comprehensive Telehealth Program on Reducing Geographic Barriers to Treatment and Improving Symptom Management in Rural Patients With Advanced Ovarian Cancer: Haller J. Smith, MD, University of Alabama at Birmingham
- Patient-Centered Education and Support for Women With Advanced Ovarian Cancer: Barbara Goff, MD, and Donna L. Berry, PhD, RN, AOCN, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance
- REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor–Related Fatigue: Alexi A. Wright, MD, MPH, and Hanneke Poort, PhD (MPI), Dana-Farber Cancer Institute.
